Parriott et al. [52] developed CAR T cells targeting PD-1, finding an anti-tumor effect for CHPD1-expressing T cells in a variety of isogenic mouse solid cancer models, including BCa (Fig. 2E). This evidence concerns the gene PDCD1 and neoplasm.